Floatz logo

lp-108

AML/MDS

Newave Pharmaceutical IncPhase 1Dormant
CC
46/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
89/ 100

Competitive context

11 Active assets in the AML/MDS cohort.

Asset / SponsorPhaseRating
Midostaurin
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 2CCC
Decitabine
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 2CCC
Azacitidine
Newave Pharmaceutical Inc
Phase 1CC
Cyclophosphamide
St. Jude Children's Research Hospital
Phase 1CC
Mana 312
Mana Therapeutics
Phase 1CC

View all 13 →

Same molecule, other indications

lp-108 is also rated in:

acute lymphoblastic leukemiaDormant
CC
Indicative ·
47 / 100
View asset →
leukemiaDormant
CC
Indicative ·
47 / 100
View asset →
chronic myelomonocytic leukemiaDormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →